Case study on sulphasalazine induced drug rash over face and body

Vijaya Sri Sowmya Dhulipudi; Naga Subrahmanyam S

doi:10.37022/jcscr.v4i2.728

Dhulipudi. Vijaya Sri Sowmya III/VI PharmD, Koringa College of Pharmacy, Korangi-533461, Tallarevu Mandal, Kakinada district, Andhra Pradesh. India.
Naga Subrahmanyam S Professor and HOD, Koringa College of Pharmacy, Korangi-533461, Tallarevu Mandal, Kakinada district, Andhra Pradesh, India.

DOI https://doi.org/10.37022/jcscr.v4i2.728

Abstract

A 36 year old female patient presented to dermatology department with complaints of redness all over the body and fever. Patient was apparently normal, when she developed a fever followed by redness starting initially over phase followed by abdomen, chest, back and upper limbs and lower limbs. Patient has the history of dry drug taken prior to onset of lesions and similar episodes in the past after taking sulfasalazine drug for rheumatoid arthritis. Patient has no history of fluid filled spaces burning maturation and general or local lesions. sulfasalazine was identified as the causative agent for this adverse drug reaction.

Keywords: Erythroderma, Drug reaction, Sulfasalazine, Rheumatoid arthritis, Fever, Cutaneous adverse drug reaction (CADR)

References

1. Azadkhan, A. K., Truelove, S. C., and Aronson, J. K. (1982). The disposition and metabolism of Sulphasalazine ( Salicylazosulphapyridine ) in man. Br. J. Clin. Pharmcol. 13(4), 6233-528. doi: 10. 1111/J. 1365-2125. 1982.tb01415.X.
2. Das, K. M., and Dubin, R. (1976). Clinical pharmacokinetics of Sulphasalazine. Clin. Pharmacokinet. 1(6), 406-425. doi: 10/2165/00003088-197601060-00002.
3. Hoult, J. R. (1986). Pharmacology and Biochemical actions of Sulphasalazine Drugs 32 (Suppl. 1 ), 18-26. doi: 10/2165/00003495-198600321-00005.
4. Nissin-Eliraz, E., Nir, E., Marsiano, N., yagel, S., and shpigel, N. Y. (2021). NF-kappa-B activation unveil’s the presence of inflammatory Hotspots in humans gut Xenografts. Plos one 16(5), e0243010 doi: 10.1371/Journal. Pone. 0243010.
5. FDA Approved Drug products: Azulfidine ( Sulphasalazine ) tablets for oral use.
6. “Sulphasalazine- induced drug reaction with eosinophilia and systemic symptoms [DRESS] complicated by HLH”. ( Frontiers in Immunology ).
7. Literature review of the clinical features of Sulphasalazine– induced DRESS / DIHS [frontiers in pharmacology 2024 ].
8. Sangineedi 1. H, et al., Asian jour Hosp pharm, Vol -5.
9. Naga Subrahmanyam. S.et al., Int J.pharm. Drug. Anal, Vol-13.
10. JAMA Dermatology – (1999) Sulfasalazine – induced hypersensitivity syndrome.
11. Naga Subrahmanyam S, Vijaya Lakshmi DT, Naga Raju GV, Pavan Kumar GV, Gayathri G, Carbamazepine Induced Drug Rash with Eosinophilia and Systemic Symptoms, Journal of Drug Delivery and Therapeutics. 2019; 9(1-s):367-368 DOI: http://dx.doi.org/10.22270/jddt.v9i1-s.2330.
12. Naga Subrahmanyam S et al., Int. J. Res. Pharm. Sci., 11(1), 173-175
13. S.nagasubrahmanyam et.al., carbamazepine induced drug rash with eosinophilia and systemic symptoms, journal of drug delivery and therapeutics, vol 9 no 1-s(2019):367-368. DOI: http://dx.doi.org/10.22270/jddt.v9i1-s.2330.
14. S.nagasubrahmanyam et.al., cefotaxime induced macular rashes, Saudi journal of medicalandpharmaceuticalsciences,vol-4,iss-9(sept,2018):1032-1034. doi:10.21276/sjmps.2018.4.9.7